Skip to content
← Back to this collection

PUBLICATIONS · 33340280

Metabolic response as assessed by (18) F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer Med
Publication date
2021 Feb
First author
Harrison DJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Harrison DJ
      type
      Author
    2. name
      Chi YY
      type
      Author
    3. name
      Tian J
      type
      Author
    4. name
      Hingorani P
      type
      Author
    5. name
      Mascarenhas L
      type
      Author
    6. name
      McCowage GB
      type
      Author
    7. name
      Weigel BJ
      type
      Author
    8. name
      Venkatramani R
      type
      Author
    9. name
      Wolden SL
      type
      Author
    10. name
      Yock TI
      type
      Author
    11. name
      Rodeberg DA
      type
      Author
    12. name
      Hayes-Jordan AA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Harrison DJ
      type
      Author
    2. name
      Chi YY
      type
      Author
    3. name
      Tian J
      type
      Author
    4. name
      Hingorani P
      type
      Author
    5. name
      Mascarenhas L
      type
      Author
    6. name
      McCowage GB
      type
      Author
    7. name
      Weigel BJ
      type
      Author
    8. name
      Venkatramani R
      type
      Author
    9. name
      Wolden SL
      type
      Author
    10. name
      Yock TI
      type
      Author
    11. name
      Rodeberg DA
      type
      Author
    12. name
      Hayes-Jordan AA
      type
      Author
    bibliography ids
    1. nci-bib-da40346a5d88864ddeef40f2
    book metadata
    content sha256
    3a3679aa5dd4b908983f4333db476a9ad08e8c1932ab99c19636fe7406920658
    document type
    citation
    dois
    1. 10.1002/cam4.3667
    electronic publication date
    display
    2020 Dec 19
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33340280
    immutable id
    pubmed:33340280@3a3679aa5dd4b908983f4333db476a9ad08e8c1932ab99c19636fe7406920658
    journal
    abbreviation
    Cancer Med
    issn electronic
    2045-7634
    issn print
    Source null
    issue
    3
    name
    Cancer medicine
    nlm unique id
    101595310
    pages
    857-866
    volume
    10
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33340280
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      d7beb1376148d9737c72fcaf35ad09c40a8e01346fbc69e3d7361abee7681f84
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2021 Feb
      precision
      month
      year
      2021
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33340280/
      title
      Metabolic response as assessed by (18) F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

      Preserved source evidence · Not medical advice